These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1467368)

  • 1. Prothymosin alpha enhances human natural killer cell cytotoxicity: role in mediating signals for NK activity.
    Cordero OJ; Sarandeses CS; López JL; Nogueira M
    Lymphokine Cytokine Res; 1992 Oct; 11(5):277-85. PubMed ID: 1467368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 killer cells: in vitro evaluation of combination with prothymosin alpha.
    López-Rodríguez JL; Cordero OJ; Sarandeses C; Viñuela J; Nogueira M
    Lymphokine Cytokine Res; 1994 Jun; 13(3):175-82. PubMed ID: 7948426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
    Ostensen ME; Thiele DL; Lipsky PE
    J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of prothymosin alpha in the human autologous mixed lymphocyte response.
    Baxevanis CN; Reclos GJ; Economou M; Arsenis P; Katsiyiannis A; Seferiades K; Papadopoulos G; Tsolas O; Papamichail M
    Immunopharmacol Immunotoxicol; 1988; 10(4):443-61. PubMed ID: 2977606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence and cytotoxicity of CD16+ CD2- subset from PBL and NK cells in long-term IL-2 cultures enhanced by Prothymosin-alpha.
    Cordero OJ; Sarandeses C; López-Rodríguez JL; Nogueira M
    Immunopharmacology; 1995 Apr; 29(3):215-23. PubMed ID: 7542644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of human T lymphocyte function by prothymosin alpha: increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytes.
    Baxevanis CN; Frillingos S; Seferiadis K; Reclos GJ; Arsenis P; Katsiyiannis A; Anastasopoulos E; Tsolas O; Papamichail M
    Immunopharmacol Immunotoxicol; 1990; 12(4):595-617. PubMed ID: 2092041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K; Tilden AB; Balch CM
    J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of biological response modifiers on lung natural killer activity.
    Lauzon W; Lemaire I
    Immunopharmacol Immunotoxicol; 1991; 13(3):237-50. PubMed ID: 1719060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytohemagglutin-stimulated human T cell: prothymosin alpha as an accessory signal.
    Cordero OJ; Sarandeses CS; Nogueira M
    J Biol Regul Homeost Agents; 1990; 4(1):7-12. PubMed ID: 2399834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
    Ostensen ME; Thiele DL; Lipsky PE
    J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells.
    Gerosa F; Tommasi M; Benati C; Gandini G; Libonati M; Tridente G; Carra G; Trinchieri G
    Cell Immunol; 1993 Sep; 150(2):382-90. PubMed ID: 8103709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.
    Nagler A; Lanier LL; Phillips JH
    J Immunol; 1988 Oct; 141(7):2349-51. PubMed ID: 3262658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
    Sun R; Li AL; Wei HM; Tian ZG
    Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
    Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K
    J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4.
    Knoblock KF; Canning PC
    Immunology; 1992 Jun; 76(2):299-304. PubMed ID: 1634252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
    Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
    Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
    Ghoneum M; Jewett A
    Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.